U.S. Paper and Forestry Products Stock News

Invivyd, Inc. ( NASDAQ:IVVD ) shareholders that were waiting for something to happen have been dealt a blow with a 31...

GDS Holdings ( NASDAQ:GDS ) Second Quarter 2025 Results Key Financial Results Revenue: CN¥2.90b (up 2.6% from 2Q 2024...

Despite an already strong run, Madrigal Pharmaceuticals, Inc. ( NASDAQ:MDGL ) shares have been powering on, with a gain...

National Energy Services Reunited ( NASDAQ:NESR ) Second Quarter 2025 Results Key Financial Results Revenue: US$327.4m...

A week ago, Toll Brothers, Inc. ( NYSE:TOL ) came out with a strong set of third-quarter numbers that could potentially...

LSI Industries ( NASDAQ:LYTS ) Full Year 2025 Results Key Financial Results Revenue: US$573.4m (up 22% from FY 2024...

Lowe's Companies, Inc. ( NYSE:LOW ) last week reported its latest second-quarter results, which makes it a good time...

Investors in The TJX Companies, Inc. ( NYSE:TJX ) had a good week, as its shares rose 3.4% to close at US$138 following...

We wouldn't blame Snap Inc. ( NYSE:SNAP ) shareholders if they were a little worried about the fact that Ajit Mohan, a...

Arq, Inc. ( NASDAQ:ARQ ) shares have continued their recent momentum with a 28% gain in the last month alone...

It is not every day that Curtiss-Wright (CW) draws attention for a sudden price pop. The company’s shares have quietly climbed over 59% in the past year, catching many investors’ eyes even without a headline-grabbing catalyst. This kind of steady upward movement, especially in the absence of dramatic news or a game-changing announcement, naturally raises questions. Is this simply a case of the market recognizing hidden value, or are buyers chasing momentum? Looking at the broader picture,...

Teradyne (TER) shares have been quietly making moves this month, catching some investors off guard. There was no headline-grabbing event to set things in motion, but the stock's recent surge of nearly 17% over the past month is hard to ignore. This kind of swing, absent a big announcement, often gets investors thinking: is something quietly shifting under the hood, or is the market simply readjusting its view on what Teradyne is worth after a stretch of sluggish performance? Looking at the...

Thinking about what to do with Broadridge Financial Solutions stock right now? You are not alone. With so many investors buzzing about where the market is headed, Broadridge has been quietly putting in the work, and its share price stories reflect that determination. Whether you are a cautious buyer or someone looking for growth upside, there is a lot here to consider. Broadridge’s recent price action makes it tough to ignore. The stock is up more than 14% year-to-date, and long-term...

Wondering whether Wolfspeed stock deserves a fresh look, or if it's best left on the sidelines? You are not alone. Investors have been scratching their heads over steep swings in share price, especially given how sharply sentiment has shifted. Over just the past year, the stock has tumbled nearly 90%, even though revenue has grown by a double-digit percentage and net income has improved at an impressive rate. It's a classic case of the market grappling with big promises for the future set...

Thinking about what to do with GE Vernova stock these days? You are not alone. Whether you are considering taking profits after a banner run or nervous about missing out, this stock has grabbed plenty of investor attention lately. After a whopping 79% year-to-date surge, a steady climb of over 30% in the past three months, and a new life at over $600 per share, GE Vernova’s momentum speaks for itself. Investors betting on the clean energy transition and infrastructure upgrades have helped...

Deciding what to do with RTX stock right now? You are not alone. This American industrial heavyweight has captured plenty of investor attention in 2024, bouncing back with an impressive 34.7% gain year-to-date. In fact, over the past year, RTX has notched a total return of 35.1%. The stock has steadily climbed out of last year’s uncertainty, in part due to rebounding defense contracts and a brightening outlook in the aerospace sector. Market sentiment seems to have shifted as well. Recent...

If you have been keeping an eye on Electronic Arts stock lately, you are probably wondering if now is the right time to jump in, cash out, or just sit tight. EA's share price has delivered some excitement over the past year, with a solid 17% total return, and a strong showing in the past quarter, climbing nearly 17%. That is the kind of run that grabs attention. It is tempting to assume the best days are yet to come, especially when big-name franchises and major market trends are in play. But...

MetLife (MET) has popped up on investors’ radars again, thanks to its recent run in the stock price. While there has not been a headline-grabbing event or major announcement, the steady climb in the share price has naturally raised some eyebrows among those weighing their next move. For investors tuned into the insurance sector, these kinds of slow-burn rallies can be just as interesting as splashy news. Sometimes, they are even more telling when it comes to forecasting value. Looking at the...

If you are eyeing Republic Services right now, you are certainly not alone. As one of the biggest names in the waste management game, RSG has been quietly churning out steady gains, attracting both growth seekers and investors who want some defensive stability in their portfolio. But the question a lot of us keep circling back to is, at these levels, is the stock actually undervalued or has all the upside been priced in? Recent stock price action gives us plenty to discuss. Over the last...

If you have been watching Lam Research lately, you know it has been quite a ride. Whether you are an investor on the fence or simply curious about this semiconductor powerhouse, there is no denying how dynamic things have become with LRCX. Over the past three months, shares have surged more than 21% as investors have warmed to the chip sector again and shrugged off broader market jitters. Year-to-date, Lam is up a robust 36%, adding to already impressive long-term gains. What is driving this...

If you are tracking Adaptive Biotechnologies (ADPT), the news that its strategic collaboration and license agreement with Genentech will be winding down might catch your attention. The deal, first signed in 2018 to jointly explore innovative cancer cell therapies, is set to terminate in early 2026. This will free Adaptive from previous exclusivity constraints in oncology. Notably, this change will unlock a $33.7 million boost in non-cash revenue later this year, adding detail to the...

If you have been watching Quest Diagnostics (DGX) lately, the recent dip in its stock price might have raised an eyebrow or two. Shares edged down about 0.4% after a period of impressive year-to-date growth. While there is no headline-grabbing event behind this move, subtle shifts like this often prompt investors to step back and re-evaluate what the market may be signaling about future prospects. Looking at the bigger picture, Quest Diagnostics has quietly outperformed many of its peers...

If you are trying to decide what to do with Stryker stock right now, you are not alone. The company’s shares have had a busy year, climbing more than 10% over the past 12 months and sitting up over 72% year to date. That is impressive, especially considering a recent dip over the past month and an overall return of more than 100% over five years. Stryker’s ability to consistently generate revenue growth and boost its bottom line has kept investors interested, even while the broader healthcare...

Procter & Gamble (PG) has turned heads after a quiet drift downward this year, with shares now sitting just below where they started twelve months ago. It is not a major announcement or earnings miss that is catching investors’ attention; rather, the subtle slide has left some wondering if the world’s biggest household products maker is setting up for a comeback or bracing for more caution from the market. On the surface, it has been an unexciting year for Procter & Gamble. The stock edged...